The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147
Papaioannou, A., Morin, S., Cheung, A. M., Atkinson, S., Brown, J. P., Feldman, S., Hanley, D. A., Hodsman, A., Jamal, S. A., Kaiser, S. M., et al. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100771 · Cited by 1,749
Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650 · cited 1×
“There are accumulating reports on osteonecrosis of the jaw developed in patients with cancer or osteoporosis who have been treated with intravenous or oral bisphosphonates after invasive dental procedures such as tooth extraction [42].”
The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis
Staa, T. P. V., Staa, T. P. V., Staa, T. P. V., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200108 · Cited by 1,294
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.253 · Cited by 1,116
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
American College of Rheumatology task force on Osteoporosis guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391104 · Cited by 848
Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., et al. (2010) · Arthritis Care & Research · doi:10.1002/acr.20295 · Cited by 708
Bisphosphonate Use and Atypical Fractures of the Femoral Shaft
Schilcher, J., Michaëlsson, K., & Aspenberg, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010650 · Cited by 695
Glucocorticoid-Induced Bone Disease
Weinstein, R. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1012926 · Cited by 694
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
Adachi, J. D., Bensen, W. G., Brown, J., Hanley, D., Hodsman, A., Josse, R., Kendler, D. L., Lentle, B., Olszynski, W., Ste.-Marie, L.-G., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708073370603 · Cited by 685
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1496::aid-art271>3.0.co;2-5 · Cited by 647
Cohen, S., Levy, R. M., Keller, M., Boling, E., Emkey, R. D., Greenwald, M., Zizic, T. M., Wallach, S., Sewell, K. L., Lukert, B. P., et al. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199911)42:11<2309::aid-anr8>3.0.co;2-k · Cited by 613
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Van Staa, T. P., Laan, R. F., Barton, I. P., Cohen, S., Reid, D. M., & Cooper, C. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11283 · Cited by 559
Saag, K. G., Zanchetta, J. R., Devogelaer, J., Adler, R. A., Eastell, R., See, K., Krege, J. H., Krohn, K., & Warner, M. R. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24879 · Cited by 493 · cited 1×
“Regarding pharmacological intervention, the efficacy of teriparatide for the treatment of GIO was reported in 2007 and 2009 [11, 12].”
Bone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Joint IOF-ECTS GIO Guidelines Working Group, Lekamwasam, S., Adachi, J. D., Agnusdei, D., Bilezikian, J., Boonen, S., Borgström, F., Cooper, C., Diez Perez, A., Eastell, R., et al. (2012) · Osteoporosis International · doi:10.1007/s00198-012-1958-1 · Cited by 335
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
Eastell, R., Reid, D. M., Compston, J., Cooper, C., Fogelman, I., Francis, R. M., Hosking, D. J., Purdie, D. W., Ralston, S. H., Reeve, J., et al. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00408.x · Cited by 315
Enhancement of Bone Mass in Osteoporotic Women with Parathyroid Hormone followed by Alendronate1
Rittmaster, R. S., Bolognese, M., Ettinger, M. P., Hanley, D. A., Hodsman, A. B., Kendler, D. L., & Rosen, C. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6614 · Cited by 307
Does a Fracture at One Site Predict Later Fractures at Other Sites? A British Cohort Study
van Staa, T. P., van Staa, T. P., van Staa, T. P., Leufkens, H. G. M., & Cooper, C. (2002) · Osteoporosis International · doi:10.1007/s001980200084 · Cited by 291
Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Toyosawa, S., Nagata, T., & Urade, M. (2010) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-010-0162-7 · Cited by 272
Self-citationGuidelines for treatment of PTSD
Foa, E. B., Keane, T. M., & Friedman, M. J. (2000) · Journal of Traumatic Stress · doi:10.1023/a:1007802031411 · Cited by 253
Diagnostic criteria of primary osteoporosis
Orimo, H., Sugioka, Y., Fukunaga, M., Muto, Y., Hotokebuchi, T., Gorai, I., Nakamura, T., Kushida, K., Tanaka, H., Ikai, T., et al. (1998) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050038 · Cited by 209
Self-citationAlendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis
de Nijs, R. N. J., Jacobs, J. W. G., Lems, W. F., Laan, R. F. J., Algra, A., Huisman, A.-M., Buskens, E., de Laet, C. E. D., Oostveen, A. C. M., Geusens, P. P. M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053569 · Cited by 208
Ringe, J. D., Dorst, A., Faber, H., Ibach, K., & Sorenson, F. (2003) · Osteoporosis International · doi:10.1007/s00198-003-1425-0 · Cited by 172
Roux, C., Oriente, P., Laan, R., Hughes, R. A., Ittner, J., Goemaere, S., Di Munno, O., Pouillès, J. M., Horlait, S., & Cortet for the ciblos study group, B. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4742 · Cited by 167
Pregnancy outcome following in utero exposure to bisphosphonates
Levy, S., Fayez, I., Taguchi, N., Han, J.-Y., Aiello, J., Matsui, D., Moretti, M., Koren, G., & Ito, S. (2009) · Bone · doi:10.1016/j.bone.2008.11.001 · Cited by 163
Reid, D. M., Adami, S., Devogelaer, J.-P., & Chines, A. A. (2001) · Calcified Tissue International · doi:10.1007/s00223-001-1060-8 · Cited by 160
Nawata, H., Soen, S., Takayanagi, R., Tanaka, I., Takaoka, K., Fukunaga, M., Matsumoto, T., Suzuki, Y., Tanaka, H., Fujiwara, S., et al. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-004-0596-x · Cited by 145
Self-citationManagement of corticosteroid-induced osteoporosis
Adachi, J. D., Olszynski, W. P., Hanley, D. A., Hodsman, A. B., Kendler, D. L., Siminoski, K. G., Brown, J. P., Cowden, E. A., Goltzman, D., Ioannidis, G., et al. (2000) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(00)80011-6 · Cited by 141
Sambrook, P. N., Kotowicz, M. A., Nash, P. T., Styles, C. B., Naganathan, V., Briffa, K., Eisman, J. A., & Nicholson, G. C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.919 · Cited by 138
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
Eastell, R., Devogelaer, J.-P., Peel, N. F. A., Chines, A. A., Bax, D. E., Sacco-Gibson, N., Nagant de Deuxchaisnes, C., & Russell, R. G. G. (2000) · Osteoporosis International · doi:10.1007/s001980070122 · Cited by 134
Amin, S., LaValley, M. P., Simms, R. W., & Felson, D. T. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.8.1512 · Cited by 127
Langdahl, B. L., Marín, F., Shane, E. J., Dobnig, H., Zanchetta, J., Maricic, M. J., Krohn, K., See, K., & Warner, M. R. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0917-y · Cited by 126
de Nijs, R. N. J., Jacobs, J. W. G., Algra, A., Lems, W. F., & Bijlsma, J. W. J. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1614-5 · Cited by 124
Prophylactic Use of Alfacalcidol in Corticosteroid-Induced Osteoporosis
Reginster, J., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., & Nielsen, K. G. (1999) · Osteoporosis International · doi:10.1007/s001980050118 · Cited by 120
Munns, C. F., Rauch, F., Ward, L. M., & Glorieux, F. H. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040711 · Cited by 113
Nationwide Survey for Bisphosphonate-Related Osteonecrosis of the Jaws in Japan
Urade, M., Tanaka, N., Furusawa, K., Shimada, J., Shibata, T., Kirita, T., Yamamoto, T., Ikebe, T., Kitagawa, Y., & Fukuta, J. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.03.051 · Cited by 113
STOCH, S. A., SAAG, K. G., GREENWALD, M., SEBBA, A. I., COHEN, S., VERBRUGGEN, N., GIEZEK, H., WEST, J., & SCHNITZER, T. J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081207 · Cited by 100
Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium
Ringe, J. D., Cöster, A., Meng, T., Schacht, E., & Umbach, R. (1999) · Calcified Tissue International · doi:10.1007/s002239900708 · Cited by 79
Ringe, J. D., Dorst, A., Faber, H., Ibach, K., & Preuss, J. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg205 · Cited by 77
Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Libanati, C. R., & Baylink, D. J. (1992) · CHEST Journal · doi:10.1378/chest.102.5.1426 · Cited by 70
Chan, B., & Zacharin, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2548 · Cited by 70
Devogelaer, J., Adler, R. A., Recknor, C. P., See, K., Warner, M. R., Wong, M., & Krohn, K. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090411 · Cited by 61
Fahrleitner‐Pammer, A., Piswanger-Sölkner, J. C., Pieber, T. R., Obermayer-Pietsch, B. M., Pilz, S., Dimai, H. P., Prenner, G., Tscheliessnigg, K., Hauge, E., Portugaller, R. H., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090216 · Cited by 57
Barriers in the management of glucocorticoid‐induced osteoporosis
Guzman-Clark, J., Fang, M. A., Sehl, M. E., Traylor, L., & Hahn, T. J. (2007) · Arthritis Care & Research · doi:10.1002/art.22462 · Cited by 53
Hakala, M., Kröger, H., Valleala, H., Hienonen-Kempas, T., Lehtonen-Veromaa, M. K., Heikkinen, J. E., Tuomiranta, T., Hannonen, P., Paimela, L., & for the ONCE trial group (2012) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2012.664647 · Cited by 49
Kirigaya, D., Nakayama, T., Ishizaki, T., Ikeda, S., & Satoh, T. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5266 · Cited by 44
Sato, S., Ohosone, Y., Suwa, A., Yasuoka, H., Nojima, T., Fujii, T., Kuwana, M., Nakamura, K., Mimori, T., & Hirakata, M. (2003) · PubMed · Cited by 39
Karras, D., Stoykov, I., Lems, W. F., Langdahl, B. L., Ljunggren, Ö., Barrett, A., Walsh, J. B., Fahrleitner‐Pammer, A., Rajzbaum, G., Jakob, F. J., et al. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110947 · Cited by 39
Corticosteroid induced osteoporosis. Guidelines for treatment.
Sambrook, P. N., DIAMOND, T. H., Ferris, L., Fiatarone-Singh, M., Flicker, L. A., MacLennan, A. H., Nowson, C. A., O'Neill, S., & Greville, H. W. (2001) · PubMed · Cited by 25
Clinical Question: What is the best approach to managing glucocorticoid-induced osteoporosis?
Compston, J. E. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03994.x · Cited by 23
Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects
Sewell, K. L., & Schein, J. R. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.16648 · Cited by 13
Warrington (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200101)44:1 · Cited by 2
Cited by
Liu, D., Ahmet, A., Ward, L., Krishnamoorthy, P., Mandelcorn, E. D., Leigh, R., Brown, J. P., Cohen, A., & Kim, H. (2013) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-9-30 · Cited by 1,268
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Evidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Self-citationPathogenesis of glucocorticoid-induced osteoporosis and options for treatment
Chotiyarnwong, P., & McCloskey, E. V. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0341-0 · Cited by 489
Clinical Practice Guideline for the Management of Chronic Kidney Disease‐Mineral and Bone Disorder
Fukagawa, M., Yokoyama, K., Koiwa, F., Taniguchi, M., Shoji, T., Kazama, J. J., Komaba, H., Ando, R., Kakuta, T., Fujii, H., et al. (2013) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.12058 · Cited by 402
Metadata
- Authors
- Suzuki, Y., Nawata, H., Soen, S., Fujiwara, S., Nakayama, H., Tanaka, I., Ozono, K., Sagawa, A., Takayanagi, R., Tanaka, H., Miki, T., Masunari, N., & Tanaka, Y.
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2014-05-13
- Volume
- 32
- Issue
- 4
- Pages
- 337-350
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2142008186
- Cited by
- 281
- References
- 56
- FWCI
- 15.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.